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The number of animals involved in laboratory testing needs to decrease,
according to the latest decrees of the European Union. Furthermore, little
is known about the secondary effects of gaseous substances (e.g.
deodorants, cleaning sprays) used on a daily basis in every household.
Based on these pressing necessities, an analysis of particle transport and
deposition has been conducted. The study has been conducted on two
levels: on a computational basis (CFD simulations) and on a practical
basis. The experimental part of the research is based on the functioning of
a lung simulator, the i-Lung. The model can be used as a passive simulator
as well as an active one.
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Starting with motivation and aim, the research topic is introduced.
Subsequently, an anatomical insight provides information about the human
respiratory tract and respiratory volumina. Conducting a study about
aerosol particle deposition in airways requires basic concepts to be
introduced, as well as production and measurement techniques. Finally, the
lung simulator model is described.
1.1 Aim
The aim of the research consists in investigating on particle flow and
deposition in a human lung simulator, the i-Lung. In particular, on the one
hand the size of aerosols particles that are inhaled by the lung simulator
and those that are exhaled will be analyzed; on the other hand the quantity
of particles deposited within the module will be identified. A numerical
analysis will be conducted, based on the geometry of the i-Lung’s airway
structure. Subsequently, an experimental validation will be performed and
compared to the results of the numerical analysis. Furthermore, differences
between literature-based knowledge on particle deposition in human lungs
and findings based on the i-Lung model will be highlighted.
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1.2 Motivation
”One of the main reasons for developing and adopting the REACH
(Registration, Evaluation and Authorization of Chemicals) Regulation was
that a large number of substances have been manufactured and placed on
the market in Europe for many years, sometimes in very high amounts, and
yet there is insufficient information on the hazards that they pose to human
health and the environment. There is a need to fill these information gaps
to ensure that industry is able to assess hazards and risks of the substances,
and to identify and implement the necessary risk management measures in
order to protect humans and the environment.” [1]
In order to gather the relevant information about hazards and benefits of
products on human health it is necessary to perform clinical testing. Very
often, it is the case that animals are involved in these kinds of testing. The
number of animals involved in these experiments increases year by year. [2]
Therefore, ”The new European chemicals policy REACh (Registration,
Evaluation and Authorization of Chemicals) has highlighted the urgent
need for further progress in the development of alternatives in order to
reduce the large projected animal use that will be its consequence.” [3]
Aside from the REACH Regulation, restrictions presented in the EU
Cosmetic Products Regulation (EC) No 1223/2009 (in act since 2013), are
also relevant for decreasing the number of animals involved in clinical
testing. Public health is the main focus area of this regulation. Rules about
consumption, packaging and labeling of animal products are defined within.
Furthermore, The Registration aborts animal testing, specifying bans on:
 Testing: testing of cosmetic products and ingredients on animals;
 Marketing: marketing finished cosmetic products which have have
undergone animal testing or which contain ingredients that have been
tested on animals. [3, 4]
In order to define a specific amount of animals involved, it is necessary
to consider the definition of cosmetics: ”A cosmetic product is any
substance or preparation intended to be placed in contact with the various
external parts of the human body or with the teeth and the mucous
membranes of the oral cavity, with a view exclusively or mainly to cleaning
them, perfuming them, changing their appearance, and/or correcting body
odors, and/or protecting them or keeping them in good condition.” [3]
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Products such as deodorants or hair-sprays are included in this definition.
These are very commonly purchased products, yet apart from their
purpose, very little is known about their secondary effects on human health.
The aim of this study was therefore to identify the effect of aerosols on the
human airways. Models and simulations of the respiratory tract have been
developed in order to find answers to these questions. In particular, their
flow path and deposition rate was be investigated. The study was carried
out on two levels: a numerical analysis and an experimental validation.
With a similar purpose, various simulators have been designed over the
past years. Some of them are based on numerical and mathematical
analysis, not including ex vivo components. The i-Lung, a lung simulator
developed in collaboration of the universities: Brno University of
Technology, College of Polytechnics Jihlava and University of Applied
Sciences Technikum Wien was the one used for the experimental validation
of this study. The collaboration between the aforementioned universities is
still ongoing, focusing research on sensors, lung replacement options and
specific breathing simulation patterns.
1.2.1 Clinical relevance
”Our respiratory system evolved to have filtration and elimination systems
that must be overcome or bypassed in the process of providing local
delivery of medications to the lung. Methods for generating aerosols,
formulating drugs, and administering medications effectively to the desired
site of action constitute the science of aerosol drug delivery.” [5] Yet not
only the health effects of casual aerosol inhalation have to be considered,
but also the consequence of those used for medicinal purposes. Over the
last 40 years, major topics in health-related aerosols have been the
preparation of suitable test aerosols, the measurement of total deposition,
the measurement of regional deposition, the development of the bolus
technique, and the study of clearance and retention.” [5]
In medicinal purposes, the main focus on aerosols revolves around particle
size and chemical properties. Indeed, the size of the particles determines
whether and where the particles will deposit. Particles that reach the
furthest sites in the respiratory organs range from a size of 0.01 µm to
12 µm. Reasons for this is their diffusion capability and the fact that larger
particles are typically deposited in the site of bifurcation of the bronchi. [5]
”For investigations of total deposition in the human respiratory tract a
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nontoxic, mono-disperse aerosol is required. The deposition is determined
by measuring the particle concentration before and after breathing,
requiring a particle of a controllable size.” [6] In order to obtain valuable
results, experiments on deposition and effect need to be conducted on
healthy volunteers. Moreover, a non-toxic aerosol needs to be applied. As
an alternative to that, a mechanical lung simulator based on the
performance of a primed porcine lung can be used. However, the research
topic should not only cover the aspects of influence in healthy lungs.
Further relevant information about breathing behavior can be extrapolated
by considering pathological breathing during aerosol exposure. The diseases





The most common types of lung diseases are the obstructive and the
restrictive condition. In the United States they constitute the second leading
cause of death after cardiac diseases. [7] It is therefore considered to be of
relevant importance to focus research projects also on these aspects.
Figure 1.1: A) Normal and (B) obstructive and restrictive exhalation flow
curves. Tkaen from [7]
A comparison between flow curves of healthy individuals and unhealthy
ones 1.1, reveals the characteristics of a normal airflow. ”In obstructive
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diseases, such as chronic bronchitis and emphysema, the maximal
expiration typically begins and ends at abnormally high lung volumes, and
the flow rates are much lower than normal. In addition, the curve may have
a scooped-out appearance. By contrast, patients with restrictive disease,
such as interstitial fibrosis, operate at low lung volumes. Their flow
envelope is flattened compared with a normal curve; but if flow rate is
related to lung volume, the flow is seen to be higher than normal.” [7] The
relationship between volume and flow has to be taken into account, since it
influences greatly drug administration in nebulizers. ”Inhaled particles
follow a complex path through the respiratory tract.” [8] Darquenne states
the strong interconnection between particle size and lung deposition.
Particles ranging 0.4-0.7 µm in size, deposit only minimally in the
respiratory tract, as their size permits them to reach further sites in the
respiratory tract. This is a common outcome in healthy individuals.
Figure 1.2 is a representation of the deposition percentage of particles with
respect to their diameter.
Figure 1.2: Particle diameter curve against the total deposition percentage.
Taken from [8]
In unhealthy individuals, the following factors influence the transport and
deposition of particles:
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 Obstruction of the airways;
 Change of dimensions of the alveoli;
 Pathological breathing patters.
Airway obstructions cause a detour in airflow towards healthy areas of
lung tissue. Hence, these specific areas are exposed to a higher load of particle
flow. Furthermore, a decreased deposition of particles in the alveolar region
is caused. A decrease in airway diameter leads to an increase in stream
velocity, leading to an increase in probability of internal impaction. [8]
1.3 Human respiration
1.3.1 Anatomical background
The breathing process begins in the nose and mouth, the inhaled air then
follows through the trachea. Subsequently, the trachea divides into two parts
named bronchial tubes. Stretching through the lungs, the bronchial tubes
divide into smaller branches named bronchioles. The flow stops at the end
of the bronchioles, where the alveoli are found. These are tiny balloon-like
sacs, and amount to 300 million in each individual. Surrounded by a mesh of
blood vessels, the alveoli exchange the inhaled air with the blood. The now
oxygen rich blood travels to the heart, that pumps it to the rest of the body.
Once the cells use the oxygen, carbon dioxide is produced and absorbed into
the blood. The carbon dioxide rich blood then flows back towards the lungs
where it is ejected during exhalation. [7], [8]
Figure 1.3 shows a representation of the human airways and alveoli. The
anatomical structure, function, location and surface area of each component
is indicated.
1.3.2 Interpreting respiratory data
In plethysmography ”lung volume” indicates the volume of gas contained
in the lungs. When conducting tests with the aid of chest radiographs, the
referred volume comprehends the volume occupied by the tissue (normal and
abnormal) as well. [9] Figure 1.4 shows a volume vs. time spirogram of
an inspiratory vital capacity (IVC). Static lung volumes and capacities are
defined as sections of the curve.
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Figure 1.3: Graphical representation of the respiratory system. The
generation number, anatomical structure, function, location and surface area
are indicated. Adapted picture from [10]
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Figure 1.4: Volume vs. time graph presenting the phases and sub-volumina
of the respiratory process. Inspiratory reserve volume (IRV); tidal volume
(VT); expiratory reserve volume (ERV); residual volume (RV); inspiratory
capacity (IC); functional residual capacity. Adapted picture from [9]
 Inspiratory reserve volume (IRV): maximal volume that can be inhaled
during tidal breathing (from the end-inspiratory stage). Approximately
3.1 L in men and 0.9 L in women;
 Tidal volume (VT): volume of gas exhaled or inhaled during the
respiration. Approximately 0.5 L in both, men and women;
 Expiratory reserve volume (ERV): maximum volume of gas that can
be exhaled from the end of expiration. Approximately 1.2 L in men
and 0.7 L in women;
 Residual volume (RV): volume of gas present within the lungs at the
end of exhalation. Approximately 1.2 L in both, men and women.;
 Inspiratory capacity (IC): maximum volume of gas that can be inhaled.
Approximately 3.5 L in men and 2.4 L in women;
 Functional residual capacity (FRC): volume of gas present during tidal
breathing (after the end of expiration). Approximately 2.3 L in men
and 1.8  L in women;
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 Total lung capacity (TLC): sum of all lung sub-volumes.
Approximately 5.8 L in men and 4.2 L in women. [9]
Other important variables that do not represent a lung sub-volume are:
 Thoracic gas volume (VTG ): absolute gas volume at any time and
alveolar pressure within the thorax. Approximately 4 L in both, men
and women;
 Vital capacity (VC): maximum volume of gas exchanged between a
complete inhalation and a slow exhalation. Approximately 4.8 L in
men and 3.1 L in women. [9]
1.4 Aerosols
An assembly of solid or liquid particles that are suspended in a gas, for a
time long enough to be detected, is named aerosol. The term was coined by
August Schamus in 1920, meaning particle carried by air. Mainly, aerosols
can originate from processes of the following two categories:
1. Natural aerosols: salt particles from sea water, volcano eruptions,
desert dust, pollen, smoke particles from forest fires, fog, viruses and
bacteria;
2. Industrial aerosols: emissions from heating, transportation vehicles,
chemical and mechanical industrial processes. [11]
Particle size and characteristics
One of the most important characteristics of aerosol particles is their size.
Assemblies that range from 1 nm up to 100 µm are identified as aerosols.
Figure 1.5 presents the complete classification of particles. However,
phenomena like charge, velocity and density play a key role. Hence, it is
reasonable to confirm that these particles behave according to both,
physical and chemical properties. Physical characteristics focus on the
friction forces, flow, velocity and acceleration. [12] In an ideal case, the
aerosol would be mono-disperse (i.e. all particles are of the same size),
however this never occurs. In reality, aerosol is therefore a poly-disperse
(i.e. particles of different sizes) assembly. Moreover, physical coagulation
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occurs between the particles, which is an additional influence to the
performance of the aerosol. [12]
Figure 1.5: Display of Particulate Matter (PM) classification depending on
diameter. Taken from [12]
1.4.1 Aerosol production
Depending on the necessities of the research, mainly two types of aerosols
can be produced: mono-disperse and poly-disperse. It is necessary to
underline that the production of mono-disperse particles is an idealization,
as the particles will still have small differences in diameter compared to
each other. Nevertheless, this differences are negligible and the gas is still
denoted as mono-disperse. Typically, mono-disperse aerosols are used for
the calibration process of devices measuring particle size. Poly-disperse
aerosols instead, are applied during the actual test performance. Hence, an
essential characteristic of an aerosol generator is its reliability on producing
the specified aerosols. [13]
Various types of generators have been designed, distinguished by the
particle type they generate. The main differentiation during production lies
in the particle state, which can be either solid or liquid. Mainly, the




Aerosols measurements can be completed with various techniques. Easier
methods are the ones that imply the collection on a filter that will be analyzed
in a subsequent process, more complex ones include complex measurement
instruments. Therefore, there is mainly a distinction between two different
categories:
 Collection of aerosols (e.g.filter) and subsequent analysis: economical,
time consuming, allow quantitative and qualitative aerosol
measurements;
 On the spot detection sensors: expensive, fast results, provide
information about size distribution. [6]
Choosing the measurement technique is therefore an important aspect,
and has to be a decision that considers all the aspect of the study to be
performed. Both techniques can therefore be suitable, depending on the
needs. [6] The most commonly used approach for measuring the mass of
particles, consists of a vibrating surface on which the particles adhere and
subsequently the change of resonance frequency can be measured by electrical
charge. However, the limitations of this technique comprise that it is suitable
only for small and sticky particles. Another popular measurement technique
consists in associating the light scattered by each particle and associating its
intensity to a specific diameter. [6]
Equivalent diameter
Equivalent diameters have been introduced since the geometric diameter of
the particles is not perfectly shaped. They refer to a parameter that is the
measurable index of the particle. [6] The assumption consists in assuming a
perfectly spherical shape and assigning its properties to the particle itself.
 Diffusion diameter: The size of particles in the sub-micrometer area
are described with a diameter that is the one of a standard-density
spherical particle that has the same diffusion rate of the one being
measured;
 Aerodynamic diameter: The aerodynamic diameter corresponds to
the one of a particle that has the same gravitational settling velocity
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as the one being measured. The introduction of this term is
particularly interesting for describing the particle inertia inside the
respiratory tract;
 Optical diameter: The optical diameter is of use when studying
optical properties of particles (e.g. light scattering). The total
amount of scattered light is given by a complex function influenced by
size, shape and other parameters such as wavelength or scattering
angle;
 Electrical mobility diameter: The electrical mobility diameter
describes the particle behavior in an induced electrical motion.
Hence, the path of the moving particle is predictable;
 Sauter mean diameter: This droplet diameter defines the surface-to-
volume-ratio with respect to all the droplets in the spray distribution.
 Projected area diameter: This approximation method consists in
measuring the area of the particle and associating to it a circle with
the same diameter. Biases of this method include the errors caused by
particles shrinking in size or mass. [6]
Figure 1.6: A) Possible external dimensions of an irregular aggregate; (B)
different diameter expressions when an irregular particle is approximate to
a sphere, (C) diameter of a sphere that has the same inertia of rotation,
and (D) diameter of the circle causing the same electro-shadow area.Taken
from [6]
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1.5 Deposition of particles in human airways
After air has been inhaled, the channels through which it passes narrow as
the alveoli are closer. This causes the flow to reduce in speed, a factor that
increases the deposit time of the particles. The main deposition mechanisms
are: impaction, settling, diffusion and interception. [15, 13] The airways of
the head and lungs have supplementary muco-ciliary transport, which enables
the deposited particles to be removed within several hours or days. As studies
show, particles ranging 1-10 µm deposit in the airways of the head; particles
ranging 0.01-1 µm remain trapped in the tracheoidal region and particles
of 0.01 µm or smaller reach the alveolar cavities. [16] Furthermore, the
gas supply in the lung lobes is strongly influenced by the geometry of the
bronchioli. Figure 1.8
Figure 1.7: Particle deposition in airways. Particles with diameter 1-10 µm
deposit in head airways (blue); particles of 0.01-1 µm diameter remain
trapped in the tracheoidal region (green) and particles of diameter 0.01 µm
remain in the alveoli (red). Taken from [16]
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Figure 1.8: Airway connection of bronchioli to lung sections. The perfusion
quantity is strongly influenced by this geometrical supply that specifically
targets regions of the lung lobes. Adapted picture from [17]
1.5.1 Stokes Law
Particle inertia is a great source of error, hence particles with greater
diameters are more problematic. Smaller particles instead follow the stream
with negligible inertia, which leads to a nearly perfect sampling. This
phenomenon is described by Stokes law as follows:
FD = 3πηV d (1.1)
Where FD is the total drag force (i.e. air resistance against the passing
particle) on a spherical particle with diameter d, moving with a velocity V
through a fluid whose viscosity is η. The concept of Stokes friction force
(Fslip or Fdrag) is introduced in order to determine the velocity of an aerosol
particle. Hence, within the range of validity of the law that corresponds to
a laminar flow (i.e. Re < 0.1), the slip correlation factor is given by 24/Re.
It is also known as the Cunningham correlation factor Cc and is essential for
the description pf particles whose size is below 1 µm. [13]
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Figure 1.9: Drag coefficient Fd, against the Reynolds number Re for spheres.
Taken from [13]
1.5.2 Reynolds number
Since aerosol is a gas mixture of particles suspended in a gas medium, the
motion of the particles largely depends on the suspension medium. Particles
with a diameter smaller than 1.0 µm are influenced by the motion of each
gas molecule, hence for the understanding of their flow basic knowledge of
the kinetic gas theory is necessary. Small particles are therefore considered
to be in a free molecular regime. On the other hand, large particles can be
regarded as in a continuous gas-like fluid and are therefore stated to be in
the continuum regime. Understanding of the gas flow pattern is essential
for clarifying what influences the measurement, within the measuring device
itself as well as at the sensors. In most cases the aerosols follow the path
of the gaseous medium, however sometimes anomalies arise due to external
forces. The Reynolds number Re is introduced in order to evaluate the level
of smoothness or turbulence of the flow pattern. It is defined by the ration









Where V is the speed of the medium, η is the dynamic gas velocity, ν is the
kinematic viscosity and dp is the diameter of the particle. [13]
With elevated friction forces, the Reynolds number is low (<2000). This
results in a laminar flow (i.e. streamlines continue following the same
direction without looping back on themselves). Instead, when the inertial
forces are higher, the Reynolds number is also high (>4000) and the flow is
turbulent (i.e. streamlines loop back on themselves and change the flow
direction abruptly). [13]
Figure 1.10: Flow around a sphere, (a) laminar flow, (b) turbulent flow
with lower Reynolds number of gas, (c) turbulent flow with higher Reynolds
number. Taken from [13]
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1.6 State of the art research on particle flow
and deposition in airways
1.6.1 CT based geometry models
Researchers have established that the most reliable studies on particle flow
and deposition in human airways are based on CT geometry of the
respiratory ducts. A benefit for using CT-based geometry is the inclusion of
all five lung lobes. In simplified models of CFD (computational fluid
dynamic) studies, symmetric lung geometries are introduced that do not
account for the five distinct lobes of the lungs and therefore cannot
conclude a relationship between particle transport and lobar ventilation. It
was shown that particle deposition is greater in the lower lobes of the lung.
Fewer particles flow through the upper lobes, with an exception of the
left-upper lobe which has an elevated quote of particle ventilation of size
2.5 µm and 5 µm. A possible justification for this phenomenon is the fact
that these particles present a lower Stokes number, and therefore do not
undergo radical deposition in the curved bronchi and bifurcations. Instead,
particles of 10, 20 and 30 µm are less free to move throughout the left lung.
More generally, there is a marked asymmetry between left and right lung.
The left lung receives a greater proportion of particles, in spite of a greater
ventilation of the right lung. Indeed, 90% of the particles at total lung
capacity (TLC) were situated in the left lung. [18] Three different features
can be identified in the human airway: the glottal constriction, cross
sectional area of the left main bronchi (LMB) and the location of the carina
with respect to the glottis and the upper trachea. Constrictions at the
glottis and at the LMB cause a high-speed flow through the trachea and
LMB. In the core region of the laryngeal jet, the particles are highly
concentrated. While traveling past the glottis and through the trachea,
they shift to the peripheral region of the jet, where they are mixed with the
residual air found within the duct. The elevated turbulent kinetic energy
(TKE) is associated to this process. The Stokes number of the particles
determines the dispersion degree. Indeed, particles with a large Strokes
number are less uniformly distributed compared to the ones with lower
values, and they are also less affected by flow disturbances. Hence, the
asymmetry of the particle distribution is further enhanced by the tendency
of particles with high Stokes number to remain in the same position.
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Studies of this particular behavior tend to agree with the concepts proposed
by Crowe et. al (1985, 1988): the Stokes number (i.e. the ratio of the
particle’s aerodynamic response time over the transit time for large
turbulent eddies) is the key for understanding dispersion in flow structures.
Indeed, for Stk  1: particles follow the motion of the fluid, whereas for
Stk  1: particles become unaffected by changes in velocity fluctuations.
Stokes number and particle distribution in the glottis are identified as the
main reasons for an asymmetric particle distribution in the lungs.
Therefore, the amount and nature of vortices in the glottis is associated to
the particle release time during inhalation. [18] This concepts serve to
conclude that in the absence of a physiologically-realistic airway model and
a large eddy simulation (i.e. considering turbulent fluctuations) the
accuracy of the model is greatly affected to a degree that does no longer
account for the asymmetric behavior of the flow.
Figure 1.11: Contours of mean particle flow velocity in a CT based airway
model. Highest velocity (red) is reached at the trachea inlet where a
narrowing of the airway occurs. Adapted picture from [18]
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Figure 1.12: Deposition ratio between upper (U) to lower lobes (L) U/L, for
the right and left lungs. Taken from [18]
Figure 1.13: Particles with 2.5 µm diameter deposit mainly at the
bifurcations of the bronchioli (left); particles with 10 µm diameter deposit
in the airways of the mouth and the first stage branching of the bronchi
(center); particles qith 30 µm diameter deposit in the pharynx, larynx and
trachea branching (right).Taken from [18]
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1.6.2 Influence of mucus lining on particle flow and
deposition
The internal lining of the airway ducts also has a great influence on the
particle flow ad deposition. Researchers have investigated on the specific
influence of the mucus lining. A feature of the mucus layer is that it
changes generation after generation, hence the study recreated a multi layer
mucus structure. Exploiting the Lagrangian particle tracking method,
particle transport and deposition were analyzed. The Larangian Discrete
Phase (DPM) model has proven to be the most suitable for considering air
as a continuum phase and particle as a disperse phase. The model considers
the interaction with the continuum phase. The particle release is
characterized by different injection properties. The boundary conditions are
defined as the velocity at the inlet and the pressure at the outlet.
Furthermore, the boundary condition of the internal walls is a trapping one.
This means that particles colliding with the internal surface remain trapped
in that position.[19]
Particle size of 1µm, 5µm and 10µm were considered during the simulation.
Following the theoretical knowledge, large particles tend to remain trapped
in the upper airways. Indeed, out of the 1016 particles of 10 mum size that
were released, 428 remained captured in the first generation whilst the rest
were exhaled. Out of all the deposited particles, 159 were deposited during
the first 100 iterations which furthermore confirms the theory. For smaller
particles, such as 5µm and 1µm a similar scenario appears, yet overall less
particles remain trapped. [19] In general, studies affirm that the all the
particles inhaled during respiration follow the air streamline. However, at
points of bifurcation and curvatures the particles tend to deposit on the
surface. By adding the mucus layer the geometry of the airways drastically
changes, in particular the inlet surface is reduced. This change results in an
alteration of the deposition pattern. The change can primarily be noticed
in the discrepancy of the data between particles of 10 µm and the smaller
ones. It appears that particles that are minor in size deposit only after the
second generation and in branches that are smaller in size. Furthermore,
the presence of mucus drastically reduces the deposition quantity of the
particles. [19]
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Figure 1.14: 3D geometry of trachea and bronchi. On the left the smooth
wall surface model, on the right the multi layered mucus representation. A
deformation of the cross sectional area given by the mucus lining is visible.
Taken from [19]
1.7 i-Lung respiration simulator
The need for lung simulators arises primarily because of the necessity for
testing mechanical respirators. Artificial respirators are used in in various
scenarios, such as surgeries or emergencies.
Figure 1.15: Necessity for lung simulators for testing of ventilators that
maintain vital parameters of patients unable to breathe (e.g. surgery,
emergency). Taken from [6]
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1.7.1 i-Lung working principle
In the past years, several models of lung simulators have been developed
mainly for educational purposes. The currently existing models can be
classified into two main categories: active and passive simulators. Active
simulators are designed to simulate active breathing lungs while passive
simulators are intended to be ventilated by an external source. However,
both models inflate a latex bag (i.e. lung equivalent) which performs
adequately for simple study purposes. The development of the used lung
simulator, the i-Lung, is described by Wurm [20]. The simulator is a
suitable choice for usage such as teaching and testing. It is possible to
combine the simulator with an aerosol generation machine in order to
obtain more sophisticated and realistic models. Moreover, it is possible to
choose between different breathing patterns, one physiological and five
pathological.
The emulation of the thoracic chamber in the i-Lung is mimicked by a
transparent box (d) made of PMMA (polymethylmethacrylate). In order to
minimize negative pressure losses, the chamber must be sealed. The
negative pressure is generated by an external vacuum pump (a), simulating
the adhesion of pleural membranes. A bellow system is used in order to
emulate the changes in intrapulmonary pressure. A ball screw is connected
to the motor through a threaded connection and to the lower section of the
bellow. Hence, an upward and downward movement is achieved by the
rotation of the ball screw through the motor. During the compression phase
of the bellows the pressure changes and induces an upward movement; on
the other hand, an extension of the bellows causes a downward
movement. [21] Figure 1.16 shows the detailed schematics of the i-Lung
functioning, whereas Figure 1.17 shows the actual lung module.
The latex bag of the i-Lung can also substituted with a primed porcine
lung. Figure 1.18a and Figure 1.18b show a sequence of photographs
representing inhalation and exhalation performed by the i-Lung based on a
biological lung.
26
Figure 1.16: Schematics of the i-Lung components and working principle.
Adapted picture from [21]
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Figure 1.17: iLung model where (a) interchangeable lung equivalent, (b)
diaphragm membrane cylinder, (c) DC motor, (d) PMMA chamber and (e)





Figure 1.18: Primed porcine lung during deflation (a) and inflation (b),
alimented by the i-Lung machine.
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1.7.2 i-Lung validation
With the aim of validating the performance of the lung simulator machine,
a set of spirometry tests was conducted. A group of volunteers was
gathered and spirometry measurements of their tidal breathing patterns
were conducted. The group was sub-dived into two equal-in-number groups,
one of individuals with smoking habits and others with no smoking habits.
The distribution of male and female participants was equal, and the age
group was defined as 22 - 30 years.
The tidal breathing of the individuals was measured 2 times per individual
and subsequently the data was averaged. It was therefore possible to obtain
a regime of volume characteristic for each subgroup and in the end compare
it with the performance of the i-Lung machine. The best visualization of
the comparison is provided by the plot of the flow curve for each category:
smokers, non-smokers and i-Lung. The graph provides clear evidence of its
reliability, highlighting a significant similarity to the flow curve of
non-smoking individuals. Hence, it was concluded that the model is
suitable for a reliable comparison to the results provided by the computer
simulations. [22]
Figure 1.19: Normalized flow curve of each category of individuals. The
strong similarity between the non-smokers and the i-Lung is highlighted and
the machine is therefore a suitable tool for the validation of the simulation’s




The study about particle flow and deposition was conducted with two
approaches: numerical simulation and experimental validation. At first,
realistic modeling of human airways was attempted. Subsequently,
numerical models of the i-Lung’s airways were realized and a CFD analysis
of aerosol flow was conducted. Validation of the results achieved through
simulations was obtained by realizing a suitable experimental setup.
2.1 Numerical analysis
The design of a suitable model representing the human airways presents
challenges of different nature. Firstly, the complexity of the geometry of
the model itself has an extensive impact on the deposition of the particles.
Secondly the smoothness of the internal walls also contributes to the outcome
of the analysis. See section 1.6.
Three models will be presented in this study:
 Realistic human airway model: dimensions are based on actual human
airways described in literature;
 i-Lung based trachea and bronchi model: dimensions are based on the
airway ducts of the lung simulator.
 i-Lung based pharynx model: for the experimental validation, a
connector tube had to be designed to connect the i-Lung to an aerosol
generator and a spectrometer. Hence, a ”pharynx” was designed with
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Inventor and 3D printed. A flow analysis was also conducted in order
to observe the behavior of the flow before entering the i-Lung.
Both models are products of a balance between realism and feasibility.
Mainly, the dimensioning is realistic whilst the surface linings are simplified
greatly. Each simulation is based on a design with Autodesk Inventor 2016,
followed by a computational fluid dynamic (CFD) analysis with CFD
Autodesk 2016. The primary aim of the flow analysis is to identify the path
of the particles and their interaction with the internal walls of the airways.
The analysis is based on Large-scale Eddies (LE) simulations and
Navier-Stokes equations for incompressible flow. LE energy containing
turbulent eddies are resolved and small-scale eddies are parametrized with

















where ui is the filtered velocity component in the i direction, p is the filtered
pressure, ρ is the fluid density, ν is the kinematic viscosity, and νT is the
SGS eddy viscosity. The properties of the fluid are ρ = 1.2 kg/m3 and ν =
1.7x 10−5m/s at ambient conditions. [18]
2.1.1 Realistic human airway model
The anatomical model of the trachea, bronchi and bronchiole was
introduced with the aim of analyzing the particle distribution and flow
within the tract. The primary interest lies in identifying the behavior of the
flow in critical zones such as the branching of airways and the change in
cross sectional area. The airway model has been created with Autodesk
Inventor, connecting cylinders of different diameters. The composition (i.e.
size and angles) is based on the anatomical structure of human airways.
[23] The edges where connection occurs have been smoothed in order to
mimic the real-life structure. In order to further minimize the complexity of
the analysis, only the right bronchi has been designed with its
correspondent bronchioli. The reason for choosing the right bronchi is the
fact that it is the one that mostly influences the respiratory volume.
Indeed, due to the difference in branching angle from the trachea, diameter
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and length, the right bronchi provides the right lung with more airflow. A
consequence of this phenomenon is the larger size of the right lung
compared to the left lung lobe.
A requirement for a finite element CFD analysis, is the meshing of the 3D
body. In order to ensure reliability of the simulation a meshing size of 0.1
has been selected. Indeed, a smaller meshing size ensures higher precision
of the outcome. This is particularly valid for models such as this, where
small changes in geometry have a large effect on the particle’s path. The
shape of the meshing elements is tetrahedral, characteristic for 3D objects
with irregular and un-symmetric geometries.
Despite the simplifications of the model, the computational time of meshing
consists of several hours, exceeding therefore an acceptable limit for
executing a continuous flow dynamics analysis. In order to overcome the
issue of very elevated computational resources, the scientific community is
currently conducting research about particle deposition basing it on CT
geometrical models. See section 1.6.
Figure 2.1: Schematic representation of the human airways. The principal
regions are identified: Trachea (T4); left bronchi (T5); right bronchi (T6).
The angle of inclination for each bronchi is indicated: left (25 ◦ ; right (45 ◦).
Taken from [24]
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Section name Section symbol Dimension
Trachea diameter T4 23 mm
Left bronchioli diameter T5 13 mm
Right bronchioli diameter T6 15 mm
Angle between O,T5 (O,T5) 25 ◦
Angle between O,T6 (O,T6) 45 ◦
Trachea length T4T3 150 mm
Larynx length T3T2 25 mm
Table 2.1: Dimensioning og the airway CAD model used for the flow analysis.
2.1.2 i-Lung based trachea and bronchi model
Based on the dimensions of the i-Lung’s airway structure, a model consisting
of the larynx, trachea and the two bronchi was designed using Autodesk
Inventor 2016. The modeled parts have the same dimensions as its anatomical
equivalent, referred to in Table 2.1. The entire structure is hollow in order for
the CFD analyzer to distinguish between surface walls and airflow. Indeed,
after importing the solid model from Inventor to CFD, it is necessary to
select all the volumes composing the model and mark them as solid parts. In
the preferences, the solid parts were identified as completely non deformable.
This is justified by the fact that the airflow exerts a force on the rigid walls,
that is negligible in comparison to the material’s deformation factors. The
hollow volume of the structure is also selected and identified as the moldable
volume. Hence, at the end of the volume selection process the model to be
analyzed is composed of two volume types: solid and liquid.
The boundary conditions are identified through pressure and flow. The inlet
surface of the model is selected and an inlet flow of 6 Lmin is applied. The
outlet surface area is selected and assigned a 0 Pa pressure. The choice of
flow and pressure as boundary conditions of inlet and outlet is a convention
used in CFD analysis with Autodesk.
2.1.3 i-Lung based pharynx model
A model of the pharynx was designed in order to connect the i-Lung with
the aerosol inlet as well as the spectrometer identifying the particles flowing.
In particular, the inlet of the pharynx model represents the connection with
the tube delivering the aerosol flow, whilst the outlet of the pharynx mode
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is connected with the trachea of the i-Lung. Hence, the real life human
anatomy of pharynx and trachea is mimicked.
Furthermore, being a particle measurement assessment necessary, the newly
designed inhalation duct (i.e. pharynx model) had to have an additional
outlet hole, through which a tube will connect it to the spectrometer.
Similarly to the trachea and bronchi model, the pharynx model was created
with Autodesk Inventor 2016 and subsequently imported in CFD in order
to conduct a flow analysis. The aim of the analysis was identifying the
path of the aerosol flow, the interaction with the internal surface walls and
the speed of flow. In analogy to the model described in 2.1.2, the pharynx
model has a hollow geometry. Thus, the shell of the model was assigned the
characteristics of a solid part, whilst the inner hollow volume was a liquid
and moldable volume. This selection process was performed as the model
was imported in CFD. Subsequently, the boundary conditions were defined.
As characteristic for flow analysis in vessels, the boundary conditions are
represented by flow at the inlet and pressure at the outlet. Indeed, the inlet
cross sectional area has been marked with an inlet flow of 6 L/min and the
outlet cross sectional area has been assigned a pressure of 0 Pa. The choice
is justified by the fact that the inlet corresponds to the connection with the
aerosol delivery tube, whilst the outlet corresponds to the connection with
the i-Lung’s trachea.
3D printing of the connector duct
After studying the model with Autodesk software for the design itself and
the computational fluid dynamics analysis, the model was printed using the
3D printer Ultimaker 2. Through the software Cura, the model was
converted from an .ipt solid Inventor file to a .stl file and modified in order
to fit the printer’s needs. In particular, small changes in geometry had to
be made in order to accommodate the size of the printer’s nozzle. The
material used for printing was bio-plastics, in order to guarantee the
precision and smoothness of the bio-compatibility and a smooth internal
structure. To further enhance the quality of the print, the highest quality
level for the print was selected. Additionally, in order to optimize the
printing a support structure was printed around it as well as within the
pipe. It is important to choose a coarse and low infill density in order to
avoid un-smooth surfaces within. Furthermore, a light and coarse internal
support structure is preferred as it is easy to remove and less likely to
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damage the internal structure of the model. All friction within the pipe
must be minimized in order to guarantee a constant flow of gas. The time
needed to print the entire object consisted in approximately 11 hours, due
to the demanded high quality of the grid.
Figure 2.2: A support structure (blue) was designed additionally in order to
provide stability during the printing of the main body (red). Three stages of




The setup in Figure 2.3 was designed in order to identify and quantify the
aerosol particles that flow in and out of the i-Lung, as well as those which
remain trapped within its structure. The testing procedure is described in
Section 2.2.2.
Figure 2.3: Block diagram of the experimental setup used for particle flow
and deposition analysis
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Figure 2.4: Setup for aerosol particle analysis. Aerosol generator (A);
Spectrometer (B); aerosol dilution flasks (C1,C2); i-Lung (D); pharynx model
(E).
Including the dilution chambers (C1, C2) was necessary in order to
minimize the coincidence level (i.e. percentage of superposition of particles
during the measurement) in the measurements. In particular, the aerosol
generator is directly connected to the C1 chamber, allowing therefore the
aerosol particles to mix with a closed volume of air. Subsequently the
mixed particles travel from chamber C1 to chamber C2, through a a wide
connection tube situated on the top of the chambers. At last, the mixed
particles are extracted from the C2 chamber and inhaled by the i-Lung.
2.2.2 Testing procedure
The i-Lung is operated by the software LabVIEW under the conditions
presented in Table 2.2. The operation window with the indicated





tidal volume 0.5 L
Table 2.2: LabVIEW operation parameters for i-Lung emulating tidal
breathing.
Figure 2.5: Operational window of the LabVIEW interface. The input
parameters presented enable the tidal breathing mode of the i-Lung. The
red oscillations on the left represent the flow; the plot on the right shows the
pressure oscillations over time during tidal breathing.
The testing procedure for obtaining the results described in the Section 3,
were the following:
1. Set the pressure of the aerosol generator (0.2 bar or 0.4 bar);
2. On the screen of the spectrometer a plot of number of particles over
concentration will appear. Allow the function to stabilize for 120 s;
3. Register the time and the values obtained for the next 60 s;
4. Import the data into the PDAnalyze software and elaborate the data
in the pre-selected range of 60 s.
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2.2.3 Aerosol production
For the process of aerosol production, the AGF 2.0 Palas GmbH was used.
The generator produces an aerosol consisting of droplets with a mean particle
diameter of 0.25 µm and a maximal diameter of 10.00 µm. [25] These values
are suitable for lung simulation because the size is appropriate for entering
the furthest airways in the lung system. The system has an adjustable binary
nozzle that enables the adjustment of the massflow.
Figure 2.6: Operation principle of the AGF 2.0 aerosol generator. Taken
from [26]
The aerosol source material is DEHS (Di-2-Ethylhexyl-Sebacat). Being
an oil, it is not hygroscopic and therefore the application in models with high
humidity values is possible. The DEHS aerosol is ejected from the generator
with a maximal mass flow rate of 4 g/h. An additional dry-air inlet had to
be introduced in order to diminish the aerosol concentration and not exceed
the measuring range of the sensor. Moreover, this additional airflow ensures
a constant aerosol transport. [25]
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2.2.4 Optical spectrometer
Figure 2.7: Optical aerosol spectrometer by PALAS complete with the
WELAS 2070 sensor. Taken from [27]
The optical aerosol spectrometers Promo 2000 by PALAS with the sensor
WELAS 2070, was used for the identification of aerosol particles. [27, 28]
The welas digital system measures the scattered light intensity of
poly-disperse particles. The determination of particle size happens via
classification of the scattered light signal to 50 a defined calibration curve
of particle diameter sections. The arrangement of measured particle sizes is
separated into different size segments and a histogram is generated. The
poly-disperse particles pass the measuring volume in the sensor system.
Through the glass fibre cables the white light illuminates the volume and
on the other side takes the detected signals for further processing to the
Promo 2000 system. By the patented T aperture the measurement
accuracy is improved in terms of border zone detection.[28]
Figure 2.8: Representation of the optical measuring system (inside the
sensor), with two glass fiber connectors, the patented T aperture, lenses






Flow velocity 5 m/s
PM amplification 1.448 V
Dilution 1
Table 2.3: Palas operational parameters for aerosol flow analysis. These
values can be selected on the spectrometer itself, before starting the
measurement.
2.2.5 Spirometry
To ensure that the i-Lung performs tidal breathing correctly, a spirometry
study was conducted. The tools used were the FlowMeter 30-D spirometer,
coupled with the ThorSoft software. More specifically, the i-Lung was
operated with the parameters described in Section 2.2.2, and a vital
capacity (VC) study was conducted. An inevitable drift in the spirometry
measurement had to be taken into account, hence the obtained data was
filtered with a low-pass filter using Matlab and a curve with no pendency




Flow range 18 L/s
Digital sampling rate 100 MHz
Flow dimensions 30 mm x 150 mm
Device dimensions 27 mm x 60 mm x 150 mm
Communication USB
Power supply USB 5V




Following the methods described in Chapter 2, results of the numerical and
experimental study were obtained. The numerical analysis presents CAD
models of the airways (human and i-Lung based), and a subsequent CFD
analysis of particle speed and flow direction from which particle deposition
can be concluded. Furthermore, the outcome of the experimental aerosol
flow and deposition analysis is portrayed.
3.1 Numerical Analysis
At first, a simplified model of the human trachea and right bronchi was
designed. Subsequently, a complete airway model based on the i-Lung’s
airway module was designed and studied.
3.1.1 Realistic human airway model
Using Autodesk Inventor 2016, a realistic model of the trachea, bronchi and
right bronchioli was designed. The geometry of the model is based on
dimensions presented in literature 2.1.1, no mucus lining was included. To
ensure a precise analysis, despite the simplifications already induced
through the elimination of the mucus lining, a meshing size of 0.1 was
intruduced based on a tetrahedron shape. The meshing time of the entire
volume comprised several hours.
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Figure 3.1: Airway representation of the trachea, bronchi and right
bronchioli. The surface was are smooth (i.e. mucus layer has been neglected
in the modeling phase). The model was realized with Autodesk Inventor
2016 and imported in FreeCAD for meshing. Meticulous tetrahedral mesh
(0.1 size) indicates the complexity of the irregular structure, leading to a
computational time of several hours.
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3.1.2 i-Lung based airway model
Figure 3.2: CAD model, designed with Autodesk Inventor 2016, of the
laryinx, pharynx, trahcea and branching bronchi of the i-Lung. The
elongated external tube represents the connection to the particle detection
machine.
Figure 3.3: CFD simulation, using Autodesk CFD 2017, of airflow through
the i-Lung based airways. The red areas, found at the narrowing of the tube,
indicate the ones where the velocity of particles is the highest (756 mm/s).
In the blue areas the flow is laminar. The slowest particle velocity can be
identified along the internal walls of the trachea (dark blue).
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3.1.3 i-Lung based pharynx model
Figure 3.4: CAD model generated with Autodesk Inventor 2016, of the
inhalation duct (i.e. i-Lung based pharynx). A small hole at the bending
spot will serve as a connector of the i-Lung to the spectrometer for aerosol
measurement.
Figure 3.5: Airflow simulation, modeled in CFD Autodesk 2017, withing
the connector duct (i.e. i-Lung based pharynx model). Red areas, at the
curvatures and narrowing of the diameter, indicate the areas where particle
velocity is at its highest (788 mm/s). Blue areas indicate locations of slow
particle flow.
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Figure 3.6: Printed pharynx model (yellow); support structure (gray) used
solely for positioning purposes.
3.2 Experimental validation
The results presented show specifics about the aerosol flow withing the i-
Lung. Concentration of aerosols, mean particle size and particle number
during inhalation versus exhalation were analyzed.
3.2.1 Particle number and concentration during tidal
breathing
The aerosol flow analysis data was processed by the PDAnalyze software
with the aim of investigating on the quantity and concentration of particles
during tidal breathing of the i-Lung. The data was observed over a time
frame of 60 s. The i-Lung was operating mimicking a human tidal
breathing pattern. Hence, the volume per breath was 0.5 L. These
alterations of the experiment were conducted:
 V ersion1: Breathing frequency of 0.2 Hz (i.e. 12 breaths/minute) and
aerosols generated at 0.2 bar pressure. The result of such conditions
is a breathing pattern that oscillates between 2500 and 1500 P/s, and
whose concentration oscillates between 40’000 and 15’000 P/cm3. See
Figure 3.7;
 V ersion2: Breathing frequency of 0.2 Hz (i.e. 12 breaths/minute) and
aerosols generated at 0.4 bar pressure. The result of such conditions is
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a breathing pattern that oscillates between 19’000 and 14’000 P/s, and
whose concentration oscillates between 640’000 and 450’000 P/cm3.
See Figure 3.8;
 V ersion3: Breathing frequency of 0.5 Hz (i.e. 30 breaths/minute) and
aerosols generated at 0.2 bar pressure. The result of such conditions is
a breathing pattern that oscillates between 14’000 and 16’000 P/s, and
whose concentration oscillates between 640’000 and 545’000 P/cm3.
See Figure 3.9.
Figure 3.7: Aerosol flow analysis within the i-Lung. The blue curve represents
the oscillation of the number of analyzed particles over time (60 s). The green
curve represents the oscillation of the concentration [P/cm3] over time. Test
parameters: tidal volume of 0.5 L ; inlet aerosol pressure of 0.2 bar; breathing
frequency of 0.2 Hz.
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Figure 3.8: Aerosol flow analysis within the i-Lung. The blue curve represents
the oscillation of the number of analyzed particles over time (60 s). The green
curve represents the oscillation of the concentration [P/cm3] over time. Test
parameters: tidal volume of 0.5 L ; inlet aerosol pressure of 0.4 bar; breathing
frequency of 0.2 Hz.
Figure 3.9: Aerosol flow analysis within the i-Lung. The blue curve represents
the oscillation of the number of analyzed particles over time (60 s). The green
curve represents the oscillation of the concentration [P/cm3] over time. Test
parameters: tidal volume of 0.5 L ; inlet aerosol pressure of 0.4 bar; breathing
frequency of 0.5 Hz.
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3.2.2 Statistical distribution of particle size
Figure 3.10: Statistical distribution of particle size during the operation of
the i-Lung. Five intervals (dark blue, red, green, light blue and yellow) of
10 s each were compared. The mean of the distribution is located at 0.25 µm.
Figure 3.11: Statistical distribution of particle size during the operation of
test structure. Five intervals (dark blue, red, green, light blue and yellow) of
10 s each were compared. The mean of the distribution is located at 0.26 µm.
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3.2.3 Statistical distribution of particle size during
inhalation and exhalation
The data presented in Figure 3.12 and Figure 3.13 shows the distribution of
particle size over time during tidal breathing (i.e. 1 L/breath) of the i-Lung
module. Each figure represents the overlapping of five intervals, each lasting
10 s.
A clear difference between inhalation and exhalation can be noted in the
maximum values of the curves. Indeed, the inhalation maximum average
corresponds to 1350 particles, on the other hand the maximum average value
during exhalation is 1250 particles. Thus, the amount of particles deposited
within the i-Lung module during tidal breathing is 100 particles, according
to the formula:
d = i− e (3.1)
where d stands for deposited particles, i stands for the amount of inhaled
particles and e represents the quantity of exhaled particles.
Figure 3.12: Statistical distribution of particle size during inhalation. Five
intervals (brown, red, light blue, dark blue and yellow) of 1 s each were
compared. The mean of the distribution is located at 0.26 µm. It can be
observed that the maximum number of inhaled particles is 1350.
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Figure 3.13: Statistical distribution of particle size during exhalation. Five
intervals (brown, red, blue, green and yellow) of 1 s each were compared.
The mean of the distribution is located at 0.26 µm. It can be observed that
the maximum number of exhaled particles is 1250.
3.2.4 i-Lung spirometry data
Figure 3.14: Spirometry data from tidal breathing pattern of the i-Lung. (a)
shows the raw data collected with the FlowMeter 30-D spirometer, a drift is





The results presented in Chapter 3 are justified and conclusions are drawn
from both, numerical and experimental study. Differences in the numerical
model of human airways and i-Lung based trachea and bronchi are
highlighted Furthermore, the results of the experimental validation are
compared to literature values.
Improvements of the numerical model as well as the experimental setup are
suggested in Section 4.4.
4.1 Numerical Analysis
The drawbacks of a numerical simplified model of the human airways are
highlighted and alternatives are presented. Subsequently, conclusions about
the particle flow path within the i-Lung airways is discussed, along with
suppositions about the deposition quantity and location of the aerosol
particles.
4.1.1 Realistic human airway model
In order to perform a valuable and reliable simulation of airflow within the
human respiratory tract, it is necessary to rely on CT geometry. Reason for
this is that small changes in geometry can have a strong impact on the flow
of particles within the duct. Hence, designing a simplified model of the
trachea, bronchi and bronchiole leads to results that are unsuitable for a
comparison to reality as well as an experimental model. See Section 1.6 and
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Section 3.
Figure 3.1 shows a CAD model of realistic human airways. The model
presents a full structure only for the right bronchi, because of the
complexity of the model. Indeed, it has been found that the meshing time
by far exceeds an accepted limit, and therefore renders the model
unsuitable for for a CFD analysis. Initially, the right bronchioli was chosen
for the modelling because previous research supports the belief that it has a
greater influence on the airflow distribution. See Section 1.6.
4.1.2 i-Lung based airway model
Figure 3.2 shows the CAD model that has been designed to represent the
i-Lung based airways. The CFD analysis that has been based on it, shows
results presented in Figure 3.3. It has been proven that the narrowing of
the ducts causes the velocity of the particles to increase, as well as that the
particles tend to flow through the right bronchi. Indeed, more particles flow
through the right bronchi and into the right lung lobe because the angle of
inclination is smaller (c.a. 25 ◦) compared to the left one (c.a. 45 ◦). This is
due to the fact that the heart is located slightly to the left within the chest.
This increase in bifurcation angle causes a higher disruption of the flow of
particles through the trachea and therefore leads to a smaller number of
particles landing in the left lung lobe. Furthermore, the right bronchi is
shorter in length due to the compression of the liver beneath but therefore
wider in diameter compared to the left bronchi. Therefore it can also be
concluded that more particles deposit in the left lobe; given its greater
angle the particles are less likely to be ejected during exhalation.
Furthermore, the locations where change of diameter occurs (e.g. from
larynx to trachea) were characterized by turbulent flow, whereas areas with
a constant diameter (e.g. along the trachea) presented laminar flow.
4.2 Experimental validation
Results have shown that the experimental setup for the measuring of particle
flow and deposition was suitable. Nevertheless, in order to further improve
the precision of the outcome a mono-disperse generator should be operated
instead of a poly-disperse one. Reason for this is the fact that by having a
poly-disperse generator the particles analyzed are of different sizes. Instead,
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by having a mono-disperse generator it would be possible to monitor the exact
quantities of particles of specific size, for both: flow rate and deposition.
4.2.1 Oscillation of particle number and concentration
during tidal breathing
Figure 3.7 shows that a pressure of 0.2 bar for the aerosol generation is too
low. Indeed, the pattern of inhalation and exhalation of the i-Lung can be
observed, both in the particle number function as well as in the
concentration function. Nevertheless, the differences in concentration and
particle number are not highlighted.
Figure 3.8 shows that by increasing the aerosol generation pressure up to
0.4 bar, the pattern of inhalation and exhalation is very clear. Indeed, the
curve representing the particle number oscillates within a definite range,
underlining the difference of particles being inhaled and exhaled. On the
other hand, the concentration curve clearly follows the pattern of the
particle number curve. A clear oscillation in concentration quantity can be
identified between inhalation and exhalation.
Figure 3.9 shows that by increasing the breathing frequency to 0.5 Hz (i.e.
30 breaths/minute), the particle number curve is no longer synchronized
with the concentration curve. This may be due to the fact that with a high
breathing frequency, the particle concentration changes swiftly within the
lungs, yet within the spectrometer the particles collide. Indeed, in this
experiment a high coincidence percentage has been observed, therefore
confirming the hypothesis that the particle number function is too slow to
adapt to elevated changes in concentration. However, this experiment had a
solely observational purpose. Being the breathing frequency during tidal
breathing 0.2 HZ, which is an equivalent to 12 breaths/minute, the inability
of the quantity function to follow the concentration function does not have
repercussions on the definition of reliability of the testing structure. In fact,
previous experiments that have been conducted on the basis of real-life
parameters were successful.
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4.2.2 Statistical distribution of particle size
Figure 3.10 indicates that the mean particle diameter observed during the
aerosol flow through the i-Lung, is 0.25 µm. In order to test the veridicity
of this result, the analysis has been conducted in an open loop, hence
without the intervening of the i-Lung. The results of the outcome of the
analysis of aerosol flow through the test structure are presented in
Figure 3.11. The latter shows that the mean diameter of the particles is
slightly bigger, in particular is measures 0.26 µm. This small shift in value
can be given by the fact that some larger particles remain trapped within
the i-Lung, whereas they continue their flow in the setup where the i-Lung
is not present. Furthermore, by removing the i-Lung from the setup, the
probability that the particles will sedimentate is reduced due to the fact
that the i-Lung itself generates a alteration in flow, during inhalation and
exhalation.
Nevertheless, this change in mean diameter is negligible and the testing
structure can therefore be considered a valid setup.
4.2.3 Statistical distribution of inhaled and exhaled
particles
Figure 3.12 presents a statistical distribution of particle size during
inhalation. The maximum number of inhaled particles in a cycle lasting 1 s
comprises c.a. 1350 particles. On the other hand, Figure 3.13 presents a
statistical distribution of particle size during exhalation. The maximum
number of exhaled particles in a cycle lasting 1 s is c.a. 1250 particles. It
can therefore be concluded that 100 particles (i.e. inhalation - exhalation =
1350 - 1250), remain trapped in the i-Lung and the adjacent tubing
structure. It must however be considered that the i-Lung does not have an
internal structure of bronchioli within its latex-lung lobes, and therefore is
a simplified representation of reality. Indeed, as presented in Section 1.6, a
high number of particles remains trapped in the bifurcations of the
vasculature within the lung lobes. On the other hand, the human airway
duct has structures such as cilia along its internal walls, that prevent
particles from depositing and sedimenting permanently. Indeed, large
particles trapped within the trachea and bronchi are transported back
upwards by these hair-like structures, where they are subsequently exhaled
from the mouth. The i-Lung model is not capable of performing such a
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complex elimination process, therefore the particles that can not be ejected
during exhalation sediment along its internal walls.
A further improvement would be the inclusion of an open system, in order
to create a continuous flow of aerosols. The system currently used is a
closed one, the aerosols particles dilute with air only in closed flasks (C1,
C2),(Figure 2.3). By introducing an open systems, the aerosols would not
accumulate and increase in concentration within the flasks. This would
result in a more equally distributed concentration of aerosols over time.
4.2.4 i-Lung spirometry data
Figure 3.14 presents the tidal breathing pattern performed by the i-Lung
during a vital capacity test. The spirometry results had to be filtered in
order to remove a gradual drift, which is given by an unknown internal
error of the spirometer itself and not by a lack of performance of the
i-Lung. The plot shows that the i-Lung is capable of emulating tidal
breathing reliably, indeed the alternations of inhaled and exhaled volumes
are symmetrical and correspond to the volumes exchanged by human lungs
(i.e. 0.5 L per inhalation and per exhalation). It can therefore be concluded
that the i-Lung has a reliable performance for a study concerned about
particle flow and deposition.
4.3 Conclusion
With the aim of investigating the aerosol particle flow and deposition
within a lung simulator, the i-Lung, two approaches have been introduced.
On the one hand, a numerical analysis has been conducted, providing
information about particle velocity and critical deposition areas within the
i-Lung airways. On the other hand, an experimental approach has led to
results that enable to draw conclusions on particle number, concentration
and dimensions during tidal breathing. It appears that the setup used for
the study, consisting primarily of a liquid aerosol generator, dilution flasks,
a spectrometer and the i-Lung leads to plausible results. To confirm the
reliability of the i-Lung simulator, a spirometry study has been conducted
and the tidal breathing volume has been categorized as correspondent to
human tidal volumes.
Particle flow analysis has shown that the aerosol concentration, along with
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the particle number, is tightly bound to the breathing pattern.
Furthermore, by analyzing the number of particles being inhaled and the
ones being exhaled by the i-Lung machine, it was possible to identify the
quantity of particles that deposit within the system.
Comparing the results of both, numerical analysis and experimental
validation to literature, the validity of both models was confirmed. Indeed,
particles of 0.25 µm size are the ones that deposit the least within an
airway system. Moreover, comparing amounts of inhaled versus exhaled
particles of a tidal breathing pattern, it was shown that a minor fraction of
aerosols remain trapped within the airways. This is partially due to the
fact that particles tend to adhere to internal linings of tubing when there is
a change of geometry and diameter (e.g. pharynx to larynx) and partially
due to the fact that the i-Lung, unlike real human airways, does not present
a cilia-lining structure that could move the trapped particles back to the
mouth opening for them to be exhaled.
4.4 Outlook
Further steps consist in conducting further CFD analysis of the i-Lung
trachea model and the connector duct, in order to define particle deposition
depending on the size. In order to obtain validation for this numerical
evaluation, an experimental study has to be conducted. The setup designed
for this study will be viable also for a size-specific particle deposition study,
however the aerosol poly-disperse generator should be substituted with a
mono-disperse generator. This will ensure a valid monitoring of alterations
in the quantity of particles entering and exiting the i-Lung, as their size will
be homogeneous.
Furthermore, testing can be extended by substituting the latex-lung lobes
with a primed porcine lung. The tests can be conducted following the same
procedure. An advantage of this study would be the identification of the
influence of an internal structure (i.e. bronchioli and alveoli) on particle
deposition and particle flow. Moreover, a truly realistic study would be the
replacement of the primed porcine lung with a fresh porcine lung.
Justification for this study would be the fact that by priming the
respiratory organ, the alveoli tend to agglomerate and collapse on
themselves. Therefore, the surface area involved in the gas exchange is
smaller in a primed organ compared to the one of a fresh organ.
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